| Medical and Health Sciences | 2021-2025 | 368 | CA 11 | 99.92 |
| Nephrology | Lifetime | 96 | CA 3 | 99.28 |
| Geriatrics and Gerontology | Lifetime | 389 | CA 29 | 88.77 |
| Nephrology | 2021-2025 | 12 | CA 1 | 99.75 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 112 | CA 5 | 98.38 |
| Health Information Management | 2021-2025 | 56 | CA 3 | 95.68 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 348 | CA 17 | 96.67 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 328 | CA 20 | 96.78 |
| General Health Professions | 2021-2025 | 589 | CA 53 | 95.27 |
| Hematology | 2021-2025 | 465 | CA 28 | 50.47 |
| Dialysis and Renal Disease Management | Lifetime | 106 | CA 8 | 99.37 |
| Chronic Kidney Disease and Diabetes | Lifetime | 131 | CA 7 | 99.12 |
| Diabetes Treatment and Management | Lifetime | 732 | CA 44 | 97.44 |
| Potassium and Related Disorders | Lifetime | 132 | CA 8 | 97.38 |
| Renal and Vascular Pathologies | Lifetime | 585 | CA 33 | 96.74 |
| Renal function and acid-base balance | Lifetime | 373 | CA 17 | 96.32 |
| Frailty in Older Adults | Lifetime | 622 | CA 52 | 96.00 |
| Central Venous Catheters and Hemodialysis | Lifetime | 701 | CA 63 | 95.70 |
| Healthcare cost, quality, practices | Lifetime | 492 | CA 44 | 94.37 |
| Acute Kidney Injury Research | Lifetime | 678 | CA 45 | 94.12 |
| Erythropoietin and Anemia Treatment | Lifetime | 435 | CA 13 | 93.92 |
| Dialysis and Renal Disease Management | 2021-2025 | 4 | CA 1 | 99.73 |
| Renal function and acid-base balance | 2021-2025 | 1 | CA 1 | 98.76 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 15 | CA 2 | 99.51 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 59 | CA 4 | 98.73 |
| Diabetes Treatment and Management | 2021-2025 | 132 | CA 8 | 98.53 |
| Potassium and Related Disorders | 2021-2025 | 19 | CA 1 | 98.02 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 354 | CA 27 | 96.63 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 227 | CA 9 | 95.66 |
| Renal and Vascular Pathologies | 2021-2025 | 137 | CA 7 | 93.61 |
| Heart Failure Treatment and Management | 2021-2025 | 513 | CA 19 | 93.86 |
| Chronic Disease Management Strategies | 2021-2025 | 440 | CA 31 | 90.22 |
| Acute Kidney Injury Research | 2021-2025 | 270 | CA 14 | 90.28 |
| Healthcare cost, quality, practices | 2021-2025 | 268 | CA 22 | 86.62 |
| Magnesium in Health and Disease | 2021-2025 | 86 | CA 5 | 80.31 |
| Artificial Intelligence in Healthcare | 2021-2025 | 967 | CA 14 | 77.01 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 436 | CA 16 | 69.20 |
| Electrolyte and hormonal disorders | 2021-2025 | 634 | CA 24 | 67.28 |
| Muscle and Compartmental Disorders | 2021-2025 | 795 | CA 39 | 50.08 |
| demographic modeling and climate adaptation | 2021-2025 | 173 | CA 5 | 49.31 |
